UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
YFOR
7301
YYForce Inc. Class A Ordinary Shares
YFOR
$923K
| $69.4K | ﹤0.01% |
55,947
+55,750
| +28,299% | +$1.24M |
2025 Q3
3 quarters
|
|
7302
Lantern Pharma
LTRN
$8.48M
| $69.4K | ﹤0.01% |
16,632
+6,555
| +65% | +$19.2K |
2021 Q1
21 quarters
|
|
7303
Amber International Holding Ltd
AMBR
$157M
| $69.3K | ﹤0.01% |
46,521
+19,735
| +74% | +$37.9K |
2025 Q2
4 quarters
|
|
7304
McCormick & Company Voting
MKC.V
$13.1B
| $69K | ﹤0.01% |
1,367
-702
| -34% | -$34.5K |
2014 Q4
46 quarters
|
|
7305
PUT
Entergy
ETR
$52.8B
| $68.9K | ﹤0.01% |
600
-8,400
| -93% | -$947K |
2026 Q1
1 quarter
|
|
7306
Sterling Capital Funds
SCEC
$600M
| $68.9K | ﹤0.01% |
2,752
+2,111
| +329% | +$52.8K |
2026 Q1
1 quarter
|
|
7307
Global X AI Semiconductor & Quantum ETF
CHPX
$174M
| $68.9K | ﹤0.01% |
+648
| New | +$56.9K |
2026 Q2
0 quarters
|
|
7308
Swiss Helvetia Fund
SWZ
$75.2M
| $68.9K | ﹤0.01% |
11,595
-35,700
| -75% | -$214K |
2014 Q4
46 quarters
|
|
7309
Acumen Pharmaceuticals
ABOS
$16.2M
| $68.8K | ﹤0.01% |
25,765
-11,381
| -31% | -$28.1K |
2023 Q3
11 quarters
|
|
7310
iShares Top 20 U.S. Stocks ETF
TOPT
$737M
| $68.7K | ﹤0.01% |
2,088
-3,141
| -60% | -$102K |
2025 Q3
3 quarters
|
|
|
GRML
7311
Greenland Mines Ltd
GRML
$52.6M
| $68.7K | ﹤0.01% |
5,285
-16,175
| -75% | -$300K |
2023 Q3
11 quarters
|
|
7312
Tuttle Capital Concentrated Memory Stack ETF
HBMX
$20.2M
| $68.6K | ﹤0.01% |
+2,196
| New | +$61.5K |
2026 Q2
0 quarters
|
|
7313
PUT
Advance Auto Parts
AAP
$2.75B
| $68.4K | ﹤0.01% |
1,100
-268,700
| -100% | -$15.2M |
2024 Q2
8 quarters
|
|
7314
PUT
Polaris
PII
$3.59B
| $68.4K | ﹤0.01% |
1,000
| – | – |
2025 Q2
4 quarters
|
|
7315
Cross Timbers Royalty Trust
CRT
$76.3M
| $68.3K | ﹤0.01% |
7,550
-12
| -0.2% | -$125 |
2014 Q4
46 quarters
|
|
7316
ProShares Ultra Technology
ROM
$954M
| $67.7K | ﹤0.01% |
436
+312
| +252% | +$40.1K |
2025 Q4
2 quarters
|
|
7317
State Street SPDR MSCI World StrategicFactors ETF
QWLD
$175M
| $67.6K | ﹤0.01% |
+445
| New | +$66.8K |
2026 Q2
0 quarters
|
|
7318
Cibus
CBUS
$90.2M
| $67.5K | ﹤0.01% |
49,301
-6,920
| -12% | -$9.9K |
2022 Q2
16 quarters
|
|
7319
Parke Bancorp
PKBK
$384M
| $67.5K | ﹤0.01% |
2,036
-2,529
| -55% | -$77.7K |
2014 Q4
46 quarters
|
|
7320
Cineverse
CNVS
$40.5M
| $67.5K | ﹤0.01% |
22,728
+11,292
| +99% | +$29K |
2023 Q4
10 quarters
|
|
7321
TScan Therapeutics
TCRX
$12.7M
| $67.5K | ﹤0.01% |
68,873
+36,389
| +112% | +$38.8K |
2022 Q2
16 quarters
|
|
7322
Baird Medical Investment Holdings
BDMD
$2.83M
| $67.5K | ﹤0.01% |
58,687
-9,176
| -14% | -$14.3K |
2024 Q4
6 quarters
|
|
7323
BingEx Ltd
FLX
$108M
| $67.4K | ﹤0.01% |
31,622
+31,528
| +33,540% | +$77.3K |
2024 Q4
6 quarters
|
|
7324
Pioneer Bancorp
PBFS
$444M
| $67.3K | ﹤0.01% |
3,945
-13
| -0.3% | -$198 |
2019 Q3
27 quarters
|
|
7325
First Trust Germany AlphaDEX Fund
FGM
$87.8M
| $67.2K | ﹤0.01% |
1,059
+946
| +837% | +$61.1K |
2026 Q1
1 quarter
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.